← Open Payments lookup

NIDIA COLOMER DE SACA: Open Payments

NPI 1790880854 · CHINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,298 in 52 payments from 10 companies in 2025. Trend: 2023 $868 · 2024 $1,030 · 2025 $1,298

Food & beverage: $1,298
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$331
Otsuka America Pharmaceutical, Inc.10$258
ABBVIE INC.9$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$135
Alkermes, Inc.4$121
Janssen Pharmaceuticals, Inc5$107
E.R. Squibb & Sons, L.L.C.3$73
Almatica Pharma LLC4$70
Teva Pharmaceuticals USA, Inc.1$30
Lilly USA, LLC1$23

Products named: INGREZZA, REXULTI, VRAYLAR, CAPLYTA, ARISTADA, INVEGA SUSTENNA, COBENFY, LOREEV XR.

Industry payments across CA — which companies pay providers there.